Bayer will discontinue phase II development candidate eliapixant
Review of development program led to reassessment of benefit-risk ratio in all four potential indications for the investigational P2X3 receptor antagonist Bayer today announced the […]
bayer
Bayer announces Christoph Koenen as new Global Head of Clinical Development and Operations
…within Pharmaceuticals Research and Development at Bayer Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations within Research and […]
Grão Direto and Bayer collaborate to expand the reach and impact of sustainable practices in grain trading
“Sustainable Practices Badge” seeks to encourage the adoption of more sustainable practices by Brazil’s grain growers Grão Direto, the largest digital platform for grain trading […]
RAGT and Bayer sign an agreement to develop hybrid wheat seeds for European markets
New partnership aims to provide farmers with new high-potential wheat varieties, enhancing sustainable agricultural practices RAGT and Bayer have entered an exclusive collaboration to jointly […]
Capital Markets Day 2021: Bayer expects dynamic growth with higher profitability
….in the coming years and is accelerating its transformation Crop Science: Clear innovation leader in its industry – expected sales and earnings growth above market […]
Bayer Fueling Growth Opportunities for Sustainable Agriculture Through Collaborative Innovation Model
Bayer Future of Farming Dialogue: Unique Open Innovation model, alongside Leaps by Bayer impact investments, drive future agricultural advancements in gene editing, plant health and […]
Horsch, The Climate Corporation announce platform agreement
Farmers will have increased opportunity to access and apply digital tools and Bayer data science capabilities Farmers around the world will have new ways to […]
Bayer receives approval for Nubeqa™ in China for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC)
The Chinese National Medical Products Administration (NMPA) has approved Nubeqa™ (darolutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at […]
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
Companies enter into a collaboration and services agreement Bayer to support CureVac in numerous areas, including development and supply of CVnCoV CureVac benefits from Bayer´s […]
Bayer Launches Large-scale Pre-launch Trial of New Tomato Varieties with Resistance to Tomato Brown Rugose Fruit Virus (ToBRFV)
The trials, which begin late September in Mexico, will target two varieties of Roma tomatoes which show little or no symptoms of ToBRFV / Developing […]
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™
Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for the treatment of metastatic […]
Bayer supports “The Challenge Initiative” of Johns Hopkins Bloomberg School of Public Health with 10 million USD
Women empowerment in times of COVID-19 “The Challenge Initiative” to scale up reproductive health for women and girls in urban poverty areas / Participating cities […]